TAT TECHNOLOGIES LTD

# Signal Note: Driehaus Growth Entry into TATT Driehaus Capital's $14.5M initiation in TAT Technologies suggests conviction in the company's pipeline or near-term catalysts, though the investment size is modest relative to the firm's $40B+ AUM. Without recent clinical data or regulatory milestones in the public domain, the timing rationale remains unclear—warrant confirmation of upcoming trial readouts, partnership announcements, or valuation inflection points that may have triggered the entry.